Additionally, liraglutide is linked to the highest rate of severe gastrointestinal side effects (23.31%), while dulaglutide has the lowest (12.29%)
Payahoo L, Khajebishak Y, Alivand MR, Soleimanzade H, Alipour S, Barzegari A, et al
Together, these findings demonstrate that, in contrast with acute exposure, chronic disruption of iron homeostasis with consequent GSH depletion remodels cellular redox homeostasis over time, inducing a state we term chronoferroptosis: a persistent ferroptotic adaptation characterized by coordinated alterations in iron-handling and antioxidant defense proteins that may represent early vulnerability to neurodegenerative pathology
Patients are randomized to pemvidutide 1.2 or 1.8 mg weekly, or placebo for 24 weeks, with primary endpoints of MASH resolution without fibrosis progression and fibrosis amelioration without MASH deterioration